Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 501

1.

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.

Orkin C, Molina JM, Negredo E, Arribas JR, Gathe J, Eron JJ, Van Landuyt E, Lathouwers E, Hufkens V, Petrovic R, Vanveggel S, Opsomer M; EMERALD study group.

Lancet HIV. 2017 Oct 5. pii: S2352-3018(17)30179-0. doi: 10.1016/S2352-3018(17)30179-0. [Epub ahead of print]

PMID:
28993180
2.

Human Immunodeficiency Virus Medicine.

Gallant JE.

J Infect Dis. 2017 Sep 15;216(suppl_5):S624-S625. doi: 10.1093/infdis/jix238. No abstract available.

PMID:
28938040
3.

Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA.

Gallant J, Hsue P, Budd D, Meyer N.

Curr Med Res Opin. 2017 Oct 6:1-11. doi: 10.1080/03007995.2017.1383889. [Epub ahead of print]

PMID:
28933204
4.

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.

Cahn P, Kaplan R, Sax PE, Squires K, Molina JM, Avihingsanon A, Ratanasuwan W, Rojas E, Rassool M, Bloch M, Vandekerckhove L, Ruane P, Yazdanpanah Y, Katlama C, Xu X, Rodgers A, East L, Wenning L, Rawlins S, Homony B, Sklar P, Nguyen BY, Leavitt R, Teppler H; ONCEMRK Study Group.

Lancet HIV. 2017 Sep 11. pii: S2352-3018(17)30128-5. doi: 10.1016/S2352-3018(17)30128-5. [Epub ahead of print]

PMID:
28918877
5.

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.

Gallant J, Lazzarin A, Mills A, Orkin C, Podzamczer D, Tebas P, Girard PM, Brar I, Daar ES, Wohl D, Rockstroh J, Wei X, Custodio J, White K, Martin H, Cheng A, Quirk E.

Lancet. 2017 Aug 31. pii: S0140-6736(17)32299-7. doi: 10.1016/S0140-6736(17)32299-7. [Epub ahead of print]

PMID:
28867497
6.

Evidence for intermolecular domain exchange in the Fab domains of dimer and oligomers of an IgG1 monoclonal antibody.

Luo Y, Raso SW, Gallant J, Steinmeyer C, Mabuchi Y, Lu Z, Entrican C, Rouse JC.

MAbs. 2017 Aug/Sep;9(6):916-926. doi: 10.1080/19420862.2017.1331803. Epub 2017 Jun 7.

PMID:
28590212
7.

The Hierarchical Cortical Organization of Human Speech Processing.

de Heer WA, Huth AG, Griffiths TL, Gallant JL, Theunissen FE.

J Neurosci. 2017 Jul 5;37(27):6539-6557. doi: 10.1523/JNEUROSCI.3267-16.2017. Epub 2017 Jun 6.

PMID:
28588065
8.

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.

Markowitz M, Frank I, Grant RM, Mayer KH, Elion R, Goldstein D, Fisher C, Sobieszczyk ME, Gallant JE, Van Tieu H, Weinberg W, Margolis DA, Hudson KJ, Stancil BS, Ford SL, Patel P, Gould E, Rinehart AR, Smith KY, Spreen WR.

Lancet HIV. 2017 Aug;4(8):e331-e340. doi: 10.1016/S2352-3018(17)30068-1. Epub 2017 May 22.

PMID:
28546090
9.

Virologic outcomes in early antiretroviral treatment: HPTN 052.

Eshleman SH, Wilson EA, Zhang XC, Ou SS, Piwowar-Manning E, Eron JJ, McCauley M, Gamble T, Gallant JE, Hosseinipour MC, Kumarasamy N, Hakim JG, Kalonga B, Pilotto JH, Grinsztejn B, Godbole SV, Chotirosniramit N, Santos BR, Shava E, Mills LA, Panchia R, Mwelase N, Mayer KH, Chen YQ, Cohen MS, Fogel JM.

HIV Clin Trials. 2017 May;18(3):100-109. doi: 10.1080/15284336.2017.1311056. Epub 2017 Apr 7.

PMID:
28385131
10.

Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States.

Chen I, Zhang Y, Cummings V, Cloherty GA, Connor M, Beauchamp G, Griffith S, Rose S, Gallant J, Scott HM, Shoptaw S, Del Rio C, Kuo I, Mannheimer S, Tieu HV, Hurt CB, Fields SD, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH.

AIDS Res Hum Retroviruses. 2017 Jul;33(7):745-748. doi: 10.1089/aid.2017.0005. Epub 2017 Apr 6.

PMID:
28384058
11.

Virological Surveillance of Influenza A Subtypes Isolated in 2014 from Clinical Outbreaks in Canadian Swine.

Grgić H, Gallant J, Poljak Z.

Viruses. 2017 Mar 21;9(3). pii: E55. doi: 10.3390/v9030055.

12.

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults.

Raffi F, Orkin C, Clarke A, Slama L, Gallant J, Daar E, Henry K, Santana-Bagur J, Stein DK, Bellos N, Scarsella A, Yan M, Abram ME, Cheng A, Rhee MS.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):226-231. doi: 10.1097/QAI.0000000000001344.

13.

A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.

Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA.

Top Antivir Med. 2017 Dec/Jan;24(4):142-151.

14.

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.

Gallant JE, Thompson M, DeJesus E, Voskuhl GW, Wei X, Zhang H, White K, Cheng A, Quirk E, Martin H.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):61-66. doi: 10.1097/QAI.0000000000001306.

15.

Eye movement-invariant representations in the human visual system.

Nishimoto S, Huth AG, Bilenko NY, Gallant JL.

J Vis. 2017 Jan 1;17(1):11. doi: 10.1167/17.1.11.

16.

Dolutegravir monotherapy: when should clinical practice be clinical research?

Gallant J, Sugarman J.

Antivir Ther. 2017;22(2):93-95. doi: 10.3851/IMP3113. Epub 2016 Dec 15. No abstract available.

PMID:
27977411
17.

Pyrcca: Regularized Kernel Canonical Correlation Analysis in Python and Its Applications to Neuroimaging.

Bilenko NY, Gallant JL.

Front Neuroinform. 2016 Nov 22;10:49. eCollection 2016.

18.

Decoding the Semantic Content of Natural Movies from Human Brain Activity.

Huth AG, Lee T, Nishimoto S, Bilenko NY, Vu AT, Gallant JL.

Front Syst Neurosci. 2016 Oct 7;10:81. eCollection 2016.

19.

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial.

Gallant J, Moyle G, Berenguer J, Shalit P, Cao H, Liu YP, Myers J, Rosenblatt L, Yang L, Szwarcberg J.

Curr HIV Res. 2017;15(3):216-224. doi: 10.2174/1570162X14666161021102728.

20.

Electric fish genomics: Progress, prospects, and new tools for neuroethology.

Pitchers WR, Constantinou SJ, Losilla M, Gallant JR.

J Physiol Paris. 2016 Oct;110(3 Pt B):259-272. doi: 10.1016/j.jphysparis.2016.10.003. Epub 2016 Oct 18.

PMID:
27769923

Supplemental Content

Loading ...
Support Center